Articles related to Cardiology, Interventional

AL amyloidosis, a rare disease with an estimated global incidence of 10 cases per million population, can present with various symptoms depending on organ involvement, making early diagnosis challenging but crucial for effective treatment.

The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.

Elevated plasma Lp(a) concentrations were associated with a 41% faster progression of peak aortic jet velocity and a 57% faster progression of mean transvalvular gradient in patients with aortic stenosis.

Rapid optimization of guideline-directed medical therapy in heart failure patients post-discharge was associated with sustained decongestion and improved clinical outcomes at 90 days.

Statins remain a cornerstone of cardiovascular disease prevention, but managing potential side effects is key to ensuring patient adherence and optimal outcomes. This article provides a comprehensive overview of statin-associated adverse effects and practical management strategies for clinicians.

A network meta-analysis of 24 trials (16,371 patients) found complete revascularization in myocardial infarction with multivessel disease reduced all-cause mortality by 15% compared to culprit-only revascularization, suggesting potential improved outcomes for this population.